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IN VITRO STUDIES OF ADRENAL STEROID METABOLISM IN
THE SKIN*
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I. CUTUKOVIC, CON. EN Sc.
The therapeutic effectiveness of topical hydro-
cortisone preparations for certain inflammatory—
chiefly eczematous—dermatoses has been well
established (1—4). Several studies have already
demonstrated that hydrocortisone penetrates
both normal and abnormal skin sites in man
(5—7), but to date there is little knowledge of
the subsequent fate of this compound following
its percutaneous absorption (8B). The present
investigation was carried out to determine
whether or not hydrocortisone undergoes active
metabolic change in the skin and, if so, in what
part of the skin this change takes place. In
addition, it seemed of interest to conduct similar
studies with cortisone—a relatively ineffective
steroid when used topically in dermatologic
therapy (8, 9)—to compare the metabolic altera-
tions of this compound and its speed of metabolic
change with the findings for hydrocortisone.
METHOD
The technic employed consisted of a series of
in vitro incubations of fresh human skin slices
with cortisone or hydrocortisonef in phosphate-
ringer buffer solution. These incubations were
followed by the extraction of steroid substances
and the separation of these compounds by paper
chromatography according to the method of
Bush (10).
Except for six tissue incubations utilizing
skin samples at post-mortem examination, all
incubations were carried out with fresh normal
human skin samples removed from surgical
specimens. Skin samples were kept in physio-
logical saline at refrigerator temperatures until
skin slices were prepared, but all incubations were
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begun within eight to ten hours after the surgical
specimen was obtained. Where cadaver skin was
used, incubations were not begun until 10—20
hours after death. Incubations with coriuxu or
epidermis alone were carried out only with fresh
skin samples after separation of these layers by
the stretch method (11).
Four to five grams of skin slices 0.5 to 1.0 mm.
thick were placed in 30 cc. of phosphate-ringer
buffer solution containing 200 micrograms per cc.
of hydrocortisone (free alcohol) or cortisone
(free alcohol) 4 The flask was placed under con-
stant agitation at 37°C for six hours, following
which the incubation was stopped by the addi-
tion of ethyl acetate.
At the end of the incubation period, extraction
of steroids from both the phosphate-ringer buffer
solution and the tissue slices was carried out with
100 cc of ethyl acetate for a period of one hour.
After repeating this procedure twice again, the
extracts were combined and the ethyl acetate
distilled off in vacuo at 37°C. The residue was
then redissolved in a final volume of 2 cc. of
methanol.
The apparatus employed for the paper parti-
tion system consisted of a covered glass tank
which was kept in a closed non-ventilated room
at about 30°C. Because of the volatility of the
solvents used, saturation of the atmosphere inside
the tank was obtained by covering the tank walls
with Whatman ' 3 filter paper which continually
soaked up both phases of the solyent system.
The chamber was always allowed to saturate
overnight prior to use.
The solvent system used was benzene (mobile
phase) and equal parts of absolute methanol and
distilled water (stationary phase).
Chromatograms were prepared from 49 cm.
strips of Whatman 43 filter paper, the flow of
the mobile phase for this length of paper requiring
about four hours. The paper was first allowed to
equilibrate for two to three hours before the
These concentrations were chosen because
they are within the limits of water solubility for
these compounds.
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mobile phase was added. All papers were run
with both the incubate extracts and standard
solutions of hydrocortisone (free alcohol) and
cortisone (free alcohol) in methanol. After
running and drying, the sheets were exposed to
an ultraviolet light source emitting nearly all of
its energy in the region of 2540A (cold quartz
mercury vapor lamp with Corning 9-54 filter).
Steroids were detected by the appearance of
dark spots on the exposed paper. The sensitivity
of the method permitted certain identification
of steroids in amounts as low as 6 micrograms
per spot. RF values were 0.24 for hydrocortisone
and 0.40 for cortisone.
RESULTS
Four 6-hour ineubations of fresh whole skin
or corium slices from three skin samples were
carried out in phosphate-ringer buffer solution
containing hydrocortisone (free alcohol) 200
micrograms per cc. On paper chromatography,
steroid extracts from all of these incubations
yielded two spots, one corresponding in RF
value to the reference standard for cortisone and
the other—representing unchanged substrate—
corresponding to the reference standard for
hydrocortisone. RF values for the spots cor-
responding to cortisone deviated from the RF
value obtained from the standard cortisone
solution by less than 0.05.
Two incubations of whole skin slices with
hydrocortisone-phosphate-ringer buffer solution
were run for three hours instead of six hours.
Paper chromatographs of the steroid extracts
showed no detectable spots except for the sub-
strate hydrocortisone.
Two 6-hour ineubations with 125—150 milli-
grams of epidermis alone added to the hydro-
cortisone-phosphate-ringer bufer solution yielded
no detectable steroid spots on chromatography
except for the substrate hydrocortisone.
Three 6-hour incubations in hydrocortisone-
phosphate-ringer buffer solution were carried out
with whole skin slices obtained from three cadaver
skin specimens. Following steroid extraction, no
spots other than those corresponding to hydro-
cortisone were detectable on chromatography.
Five 6-hour ineubations of fresh whole skin
or corium slices from four skin samples were
carried out in phosphate-ringer buffer solution
containing cortisone (free alcohol) 200 micro-
grams per cc. On paper chromatography steroid
extracts from all of these incuhations yielded two
spots, one corresponding in RF value to the
reference standard for hydrocortisone and the
other—representing unchanged substrate—cor-
responding to the reference standard for corti-
sone. RF values for the spots corresponding to
hydrocortisone deviated from the RF value of
the standard hydrocortisone solution by less than
0.05.
Two 6-hour incubations with 125—150
milligrams of epidermis alone added to the
cortisone-phosphate-ringer buffer solution yielded
no detectable steroid spots on chromatography
except for the substrate cortisone.
Two incubations of whole skin slices with
cortisone-phosphate-ringer buffer solution were
run for three hours instead of six hours. On paper
chromatoraphy steroid extracts from these
incubations yielded two spots, one corresponding
in RF value to the reference standard for hydro-
cortisone and the other to the reference standard
for the substrate cortisone.
Three 6-hour incubations in cortisone-phos-
phate-ringer buffer solution were carried out with
whole skin slices obtained from three cadaver
skin specimens. Following extraction of steroids,
no other spots other than those corresponding to
cortisone were detectable on paper chromatog-
raphy.
Three incubations of fresh whole skin slices
from three skin specimens were carried out in
phosphate-ringer buffer solution containing pred-
nisone 200 micrograms per cc. Three similar
incubations were carried out in phosphate-ringer
buffer solution containing prenisolone 200
micrograms per cc. These incubations were
stopped after 5, 6, and 9 hours. Following
extraction of steroids, chromatography yielded
no spots other than those corresponding to ref er-
ence standards for the substrates.
From two papers run with steroid extracts of
fresh skin incubations, the spots corresponding to
the metabolic transformation products of hydro-
cortisone and cortisone were eluted with meth-
anol. The eluates were then rerun on paper to-
gether with standard solutions of hydrocortisone
and cortisone according to the method described
above. The RF value of the transformation
product of hydrocortisone, which previously
had been identical to that of cortisone, again
corresponded to that of the standard cortisone
solution. Similarly, the R value of the trans-
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formation product of cortisone, which previously
had been identical to that of hydrocortisone,
again corresponded to that of the standard hy-
drocortisone solution. In addition, samples of
these same eluates were then run in a different
solvent system (mobile phase: light benzene and
petroleum; stationary phase: methanol and
water) (10). The steroid transformation product
previously recovered following tissue incubation
with hydrocortisone again corresponded in R
value to the control solution of cortisone. The
steroid transformation product recovered from
tissue incubations with cortisone also cor-
responded in RF value to the control solution of
hydrocortisone.
Several control incubations were run at 370 C
with 30 cc. of phosphate-ringer buffer solution
alone and with the same solution containing
four to five grams of whole skin without the
addition of hydrocortisone or cortisone. These
incubations were "stopped" at the end of six
hours by addition of ethyl acetate, following
which they were "extracted" with ethyl acetate
as previously described. No spots were detectable
on paper chromatography following these control
procedures. Similar control "incubations" carried
out with phosphate-ringer buffer solution con-
taining either hydrocortisone or cortisone, 200
micrograms per cc., failed to yield any spot on
paper chromatography other than that corre-
sponding to the steroid orginally added.
Several papers obtained from extracts of fresh
skin incubations with either hydrocortisone or
cortisone were sprayed with a solution of NaOH
in methanol. This technic, recommended by Bush
(10) for increasing the sensitivity of the method
used for the detection of aB-unsaturated keto-
steroids, failed to show additional steroid spots
on any of the papers examined.
rnscussloN
Numerous investigations have demonstrated
the capacity of various tisues to effect the chemi-
cal transformation of steroid hormones added to
in vitro systems. Much of this work has been
summarized in two comprehensive reviews (12,
13). In addition Wilson et al have published a
series of reports on the in vivo metabolism of
hydrocortisone and cortisone in the human
synovial cavity (14—16).
As regards steroid metabolism in the skin, the
relationship of the physiological activity of the
specific hormone with its possible chemical
transformations has always been of interest. The
anti-inflammatory effects of cortisone and
hydrocortisone are not markedly different when
these compounds are administered systemically.
Yet, despite apparently comparable absorption
of these hormones through the skin (5, 17)
topical hydrocortisone is impressively anti-
inflammatory in the treatment of certain eczem-
atous dermatoses (1—4) while locally applied
cortisone is relatively ineffective (8, 9). It has
been postulated that the difference in topical
therapeutic efficacy of these compounds might
be related to differences either in the pathways of
metabolism or in the speed of metabolic inctiva-
tion of these steroids in the skin. These alterna-
tive explanations, however, have been further
based on the premise that hydrocortisone and
cortisone actually undergo metabolic alteration
in the skin before passage into the systemic circu-
lation. The present study was undertaken to
examine both of these problems more closely.
That adrenal steroid metabolism may actually
take place in the skin has been shown by thee
in vitro studies described. Since metabolic change
was demonstrable only with tissue slices of whole
skin or corium it can be concluded that alteration
of hydrocortisone or cortisone occurs mainly in
the connective tissue. Nonetheless, while incu-
bation studies with epidermis were negative,
epidermal specimens with tissue weights com-
parable to those of the corium must be evaluated
before concluding that metabolic alteration of
these compounds occurs in the dermis alone.
Some inferences can now be drawn concerning
the metabolic pathways of hydrocortisone and
cortisone in human skin. The six hour in vitro
incubation studies indicate that hydrocortisone
(free alcohol) is partly converted into a com-
pound possessing the paper chromatographic
characteristics of cortisone. Similarly, under
comparable experimental conditions, cortisone
(free alcohol) is partly converted into a com-
pound possessing the paper chromatographic
characteristics of hydrocortisone. Although no
attempts were made in either case to determine
quantitatively the precise extent of this con-
version, it could be estimated from the known
limits of sensitivity of the method used that at
least 10% of the steroid substrate had undergone
metabolic alteration.
While further studies are necessary to establish
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FIG. 1. Sulfuric acid chromogen absorption
spectra of hydrocortisone (a), cortisone (b), and
hydrocortisone metabolite (c).
the identity of the cortisone conversion product,
it would not be surprising to find that hydro-
cortisone occurs as a metabolic product of corti-
sone in the skin. Metabolic conversion of cortisone
in part to hydrocortisone has already been
described following systemic administration of
cortisone to humans (18—21). Similar findings
have also been recorded following in vitroincuba-
tions of certain animal tissues or organs with
cortisone (22, 23). It is of interest, too, that
hydrocortisone is found among the products of
cortisone metabolism both in the rabbit eye (24)
and in the human synovial cavity (14—16),
although in the eye, cortisone is an effective
anti-inflammatory agent (25) while in the joint
cavity its anti-inflammatory properties are unim-
pressive in contrast to the action of hydrocorti-
sone (26, 27).
The occurrence of cortisone among the urinary
metabolic products of hydrocortisone in man has
been described by Burstein et at (28). Although
McEwen and his collaborators (14) isolated from
synovial fluid a compound with the paper
chromatographic characteristics of cortisone
following the intraarticular injection of hydro-
cortisone, further studies showed this substance
to have a different sulfuric acid chromogen
absorption curve (29) from cortisone. Subsequent
investigations have confirmed the fact that
cortisone is not found among the synovial tissue
metabolites of hydrocortisone (16). Our own
studies with human skin have shown that in
tissue incubations with hydrocortisone the
compound formed possessing the chromato-
graphic mobility of cortisone also yields a sulfuric
acid chromogen absorption curve which differs
from that of both cortisone and hydrocortisone
(Fig. 1). In fact, the curve for this compound
strorigly resembles the absorption curve for the
compound isolated by McEwen et al (14) follow-
ing injection of hydrocortisone into the synovial
cavity. Additional studies will be required to
identify this substance further.
The striking differences between the anti-in-
flammatory effects of hydrocortisone and corti-
sone applied locally to the skin remain unex-
plained. As Wilson and her collaborators have
emphasized for the therapeutic disparity in
synovial tissue (16), the simplest explanation
would be that hydrocortisone itself is the effective
anti-inflammatory agent and that inadequate
quantities of cortisone are transformed into
hydrocortisone in situ. As these same authors
emphasize, this explanation is unsatisfactory,
however, since the systemic administration of
cortisone is followed by only a relatively small
yield of hydrocortisone while numerous additional
metabolites of cortisone can also be recovered
from the urine (16). The comparable anti-
inflammatory effects of hydrocortisone and
cortisone following systemic administration
rather suggest that in regard to local application,
there are perhaps certain tissues capable of trans-
forming hydrocortisone into a low yield of one
or more potent anti-inflammatory agents which
these same tissues cannot produce—or produce
in inadequate amounts—from the substrate
cortisone (16). The well known anti-inflammatory
effects of cortisone injected intradermally (8, 8A)
could also be explained by such a theory on the
basis that the skin is presented with such a
large amount of substrate that the ordinarily
poor yield of anti-inflammatory compounds is
now adequate. Altogether, this attractive hypoth-
esis certainly bears further investigation as it
relates to steroid metabolism in the skin.
The present studies indicate that a second
explanation may also be advanced for the con-
trast in local effects of hydrocortisone and corti-
sone in the skin. The three hour incubation
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studies have shown that there is some metabolic
alteration of cortisone during this time interval
but that no transformation of hydrocortisone is
demonstrable. Similar in vivo differences in the
rate of metabolism of hydrocortisone and corti-
sone have been described previously. Malkinson
et at (17), working with human volunteers,
found that after topical application of cortisone-
4-C'4 acetate to normal human skin sites, peak
urinary excretion of radioactive metabolites was
demonstrable within the first 24-hour period.
In comparable studies with hydrocortisone-4-
C'4 (free alcohol) the peak urinary excretion of
radioactive material occurred in the second rather
than the first 24-hour period. Similarly Sandberg
et at (30) found that after oral administration of
cortisone or hydrocortisone, the steroid degrada-
tion products of cortisone appeared in the urine
at a more rapid rate than the degradation prod-
ucts of hydrocortisone. The present in vitro
findings indicate, then, that the skin metabolizes
cortisone more readily and perhaps more rapidly
than it does hydrocortisone, suggesting that
speedier inactivation of cortisone or cortisone
metabolites may taken place. Obviously if this
rate of metabolic inactivation in the skin were
sufficiently rapid, the anti-inflammatory effect
of this steroid could be drastically reduced.
In regard to the speed of adrenal steroid
metabolism in the skin, it also seems worthwhile
to comment briefly on the fact that three skin
incubations carried out with prednisone and
prenisolone showed no metabolic changes in these
compounds during incubation periods of 51,, 6,
and 9 hours. These preliminary findings for both
compounds are of interest in the light of recent
investigations (31) which have shown that the
increased anti-inflammatory potency of predni-
sone and prednisolone in humans may be related
to the much slower metabolism of these com-
pounds in body tissues as contrasted with corti-
sone and hydrocortisone. Further support for this
hypothesis as it concerns the treatment of skin
diseases may be obtained from the observation
of Frolow, Witten, and Sulzberger (32) topical
prednisone—the analogue of cortisone—is equally
as effective as topical prednisolone—the ana-
logue of hydrocortisone—in its anti-inflammatory
effects.
SUMMARY
Studies have been conducted on the in vitro
metabolism of adrenal steroids in the skin.
Extraction and chromatographic separation of
steroids from tissue incubates have shown
that:
1. Hydrocortisone (free alcohol) and cortisone
(free alcohol) are actively metabolized by the
skin, and that this metabolic transformation
occurs mainly in the corium.
2. The single metabolic product of hydro-
cortisone detectable by the technics employed
possess the paper chromatographic characteris-
tics of cortisone. Sulfuric acid chromogen absorp-
tion curves indicate, however, that this substance
is not cortisone, and further studies are required
to establish the identity of this compound.
3. The single metabolic product of cortisone
detectable by the technic employed possesses
the paper chromatographic characteristics of
hydrocortisone. Additional studies will be
necessary to establish firmly the identity of this
compound.
4. Under the experimental conditions described,
the quantitative yield of the metabolic conver-
sion products of hydrocortisone or cortisone is
at least 10%.
5. The metabolic alteration of cortisone occurs
more rapidly than the metabolic alteration of
hydrocortisone in the skin.
The significance of these findings is discussed,
particularly in relation to the striking differences
in the anti-inflammatory potency of hydrocorti-
sone and cortisone following local application
to the skin.
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DISCUSSION
DR. JOHN H. EPSTEIN (San Francisco, Calif.): inactive steroid products. Perhaps cortisone is
I enjoyed Dr. Malkinon's presentation very rapidly metabolized to this substance, accounting
much. I would just like to ask whether tetra- for its lack of clinical efficacy.
hydrocortisone was considered as one of the DR. CLARENCE S. LIVINGOOD (Detroit, Michi-
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gan): It would be interesting for Dr. Malkinson
to compare these results with studies of the other
steroids which are effective topically.
Dn. FREDiRICK D. MALKINSON (in closing): I
would like to thank those who discussed this
paper. Since precise identification of the metabolic
conversion products of cortisone and hydrocorti-
sone has not been completed I cannot say whether
tetrahydrocortisone is formed in the skin. It is
generally assumed that this inactive metabolite
is formed in the liver and it has been shown in the
case of other peripheral tissues—especially
synovial tissue—that formation of tetrahydro-
cortisone does not take place locally. We do know
from previous studies with C14 labeled hormones
that tetrahydrocortisone and tetrahydrohydro-
cortisone can be recovered from the urine follow-
ing application of cortisone and hydrocortisone
respectively to normal human skin. The site of
this metabolic change following percutaneous
absorption has not yet been identified but I
suspect it is chiefly the liver.
As far as in vitro metabolism of other steroids
is concerned we have done some preliminary
studies which are included in the text for publica-
tion but were omitted from the presentation. In
tissue incubations with prednisone and with
prednisolone for periods of 5, 6, and 9 hours
we were unable to demonstrate formation of any
conversion products. This is of interest in the
light of recent findings by Slaunwhite and Sand-
berg that the metabolism of prednisone and
prednisolone in humans proceeds much more
slowly than that of cortisone and hydrocortisone.
it is assumed that the slower rate of metabolism
may be responsible for the enhanced anti-inflam-
matory effects of these newer compounds. Our
preliminary findings of delayed metabolism of
prednisone and prednisolone in the skin are also
of interest in relation to the observations of
Frolow, Witten, and Sulzberger that the topical
application of prednisone—the analogue of corti-
sone-is as effective in eczematous dermatoses
as the local application of prednisolone, the
analogue of hydrocortisone.
